Close

Teva Pharma (TEVA) Announces U.S. Launch of Generic Actonel Tabs

June 1, 2015 8:35 AM EDT Send to a Friend
Teva Pharma (NYSE: TEVA) announces the launch of the generic equivalent to Actonel (risedronate sodium) Tablets, 5 mg, 30 mg ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login